West Pharmaceutical Services Future Growth
How is West Pharmaceutical Services forecast to perform in the next 1 to 3 years based on estimates from 10 analysts?
Future Growth Score
1/6Future Growth Score 1/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
8.8%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 3,388 | 769 | 682 | 920 | 3 |
12/31/2024 | 3,163 | 664 | 522 | 790 | 8 |
12/31/2023 | 2,903 | 582 | 370 | 664 | 10 |
9/30/2022 | 2,909 | 631 | 388 | 654 | N/A |
6/30/2022 | 2,929 | 686 | 402 | 675 | N/A |
3/31/2022 | 2,881 | 684 | 382 | 647 | N/A |
12/31/2021 | 2,832 | 662 | 331 | 584 | N/A |
9/30/2021 | 2,681 | 613 | 341 | 572 | N/A |
6/30/2021 | 2,523 | 519 | 287 | 500 | N/A |
3/31/2021 | 2,326 | 423 | 307 | 504 | N/A |
12/31/2020 | 2,147 | 346 | 298 | 473 | N/A |
9/30/2020 | 2,037 | 312 | 272 | 430 | N/A |
6/30/2020 | 1,945 | 286 | 277 | 420 | N/A |
3/31/2020 | 1,888 | 261 | 247 | 377 | N/A |
12/31/2019 | 1,840 | 242 | 241 | 367 | N/A |
9/30/2019 | 1,792 | 230 | 215 | 334 | N/A |
6/30/2019 | 1,767 | 229 | 201 | 314 | N/A |
3/31/2019 | 1,745 | 219 | 186 | 291 | N/A |
12/31/2018 | 1,717 | 207 | 184 | 289 | N/A |
9/30/2018 | 1,711 | 155 | 193 | 297 | N/A |
6/30/2018 | 1,677 | 151 | 172 | 284 | N/A |
3/31/2018 | 1,627 | 133 | 166 | 288 | N/A |
12/31/2017 | 1,599 | 151 | 133 | 263 | N/A |
9/30/2017 | 1,566 | 190 | 105 | 254 | N/A |
6/30/2017 | 1,544 | 176 | 83 | 246 | N/A |
3/31/2017 | 1,535 | 182 | 68 | 237 | N/A |
12/31/2016 | 1,509 | 144 | 49 | 219 | N/A |
9/30/2016 | 1,487 | 138 | 48 | 216 | N/A |
6/30/2016 | 1,454 | 102 | N/A | 216 | N/A |
3/31/2016 | 1,426 | 85 | N/A | 217 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: WST's forecast earnings growth (8.8% per year) is above the savings rate (2%).
Earnings vs Market: WST's earnings (8.8% per year) are forecast to grow slower than the US market (13.8% per year).
High Growth Earnings: WST's earnings are forecast to grow, but not significantly.
Revenue vs Market: WST's revenue (5.9% per year) is forecast to grow slower than the US market (6.9% per year).
High Growth Revenue: WST's revenue (5.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: WST's Return on Equity is forecast to be low in 3 years time (18%).